Vaginal brachytherapy cuts mortality in early uterine cancer
(HealthDay)—For women along with surgically staged IA or IB endometrial adenocarcinoma, use of vaginal brachytherapy (VB) is associated with a reduction in mortality, according to a study published online August. 10 in Cancer.
Related Posts:ASCO develops recommendations for invasive cervical…New study links drinking behaviors along with mortalityEORTC-ETOP study opens on pembrolizumab designed for…Low FODMAP diet cuts irritable bowel syndrome symptomsFox Chase trial tests promising therapy in early breast…The post Vaginal brachytherapy cuts mortality in early uterine cancer appeared first on My Irrit...
Source: My Irritable Bowel Syndrome Story - August 16, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Rosacea tied to higher risk of GI illnesses
(HealthDay)—Rosacea is associated with improved risk of some gastrointestinal illnesses, according to a study published online Aug. 8 in the British Journal of Dermatology.
Related Posts:Initial screen for genetic risk aspects of IBS in the…Individuals with IBS often have negative medical care…ASCO develops recommendations for invasive cervical…Vaginal brachytherapy cuts mortality in early uterine cancerNon-celiac wheat sensitivity may be an allergyThe post Rosacea tied to higher risk of GI illnesses appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritable Bowel Syndrome Story)
Source: My Irritable Bowel Syndrome Story - August 15, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Genes linked to people ’ s bowel habits
A new publication in the scientific diary Gut sheds light on the function that certain genes have in identifying how people differ in their bowel habits. The study results from the collaboration of research groups at Karolinska Institutet and the University Medical Centre Groningen, Groningen, the Netherlands.
Related Posts:Connection between genes that make cells deaf to messages…Initial screen for genetic risk aspects of IBS in the…Important advance in the fight against skin cancerProbiotics and the gut-brain axisScientists find genetic clue to irritable bowel syndromeThe post Genes linked to people’s...
Source: My Irritable Bowel Syndrome Story - August 11, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
How naive T cells decline with age
AIM, within the Institute for Basic Science (IBS), released an intriguing paper in Scientific Reports, on August 2, describing a novel explanation to a issue known to immunologists for decades: What causes the particular decline in immunity in outdated individuals? As soon as we are born we are destined to age, it’s a natural law which everyone adheres in order to. As we grow older our immunity gradually diminishes to a point where it is no longer able to effectively orchestrate an immune system response to fight and extinguish pathogens. The flu vaccine, for example , is only 17 to 53 percent effective in people age...
Source: My Irritable Bowel Syndrome Story - August 2, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Stomach disorders involve both brain-to-gut plus gut-to-brain pathways
New research indicates that in patients with irritable bowel syndrome (IBS) or indigestion, there is a distinct brain-to-gut path, where psychological symptoms begin first, and separately a distinct gut-to-brain pathway, where gut symptoms start first.
Related Posts:Brand new study finds link between depressive disorder and…Group suppresses oxidative stress and neuronal death…Probiotics and the gut-brain axisCan changes in the brain affect your microbiome?Chronic abdominal pain often linked to emotional…The post Stomach disorders involve both brain-to-gut plus gut-to-brain pathways appeared first on My...
Source: My Irritable Bowel Syndrome Story - July 22, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Research team identifies a neuron signal controlling molecule
A research group led by Professor Seyun Kim of the Department of Biological Sciences at Korea Advanced Institute of Science and Technology (KAIST) has identified inositol pyrophosphates as the chemical that strongly controls neuron signaling via synaptotagmin.
Related Posts:Brand new optogenetic tool for controlling neuronal…The simplistic beauty of a free radicalGroup suppresses oxidative stress and neuronal death…Alzheimer’s disease markers could be identified via…Researchers report breakthrough inhibition of intestinal…The post Research team identifies a neuron signal controlling molecu...
Source: My Irritable Bowel Syndrome Story - July 22, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Customized rye bread helps patients along with irritable bowel syndrome
Patients with irritable bowel syndrome (IBS) are often concerned that certain foods might trigger or worsen their signs and symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called “FODMAPs” (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS signs and symptoms than patients who ate regular rye bread.
Related Posts:Low FODMAP diet cuts irritable bowel syndrome symptomsBrand new study finds link between depressive disorder and…What is Irritable Bowel SyndromeDoes High Stress Levels and Anxiety C...
Source: My Irritable Bowel Syndrome Story - July 18, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Chemoradiotherapy after surgery for gastric malignancy shows similar outcomes to post-operative chemotherapy
Post-operative treatment intensification with chemoradiotherapy does not achieve much better outcomes when compared to post-operative chemotherapy in patients with gastric cancer who have already undergone pre-operative chemotherapy, according to stage III data presented at the ESMO 18th World Congress of Stomach Cancer in Barcelona, Spain.
Related Posts:Radioimmunotherapy, Gemcitabine combination shows early…Adjuvant chemotherapy improves overall survival in patients…Combining epigenetic therapies with immunotherapies likely…New IBS treatment shows possible in Phase 2 researchImmuno and targeted thera...
Source: My Irritable Bowel Syndrome Story - June 30, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Experts create key diagnostic measures with regard to gastrointestinal disorders
With no lab test available to diagnose functional stomach disorders, proper diagnostic criteria are usually critical for clinicians to make an accurate determination of what ails their individuals.
Related Posts:Breathing test may help diagnose irritable intestinal…Positive diagnostic strategy non-inferior to exclusion in…Research reveals how relaxation response might help treat 2…New blood test could help millions of patients with…Intestinal condition could hold key in order to developing…The post Experts create key diagnostic measures with regard to gastrointestinal disorders appeared f...
Source: My Irritable Bowel Syndrome Story - June 21, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Researchers report breakthrough inhibition of intestinal tract tumors in mice models
Scientists from the Institute for Fundamental Science (IBS) have successfully inhibited the growth of colon cancers in mice with mismatch repair deficiency. The research team, headed with the Center’s director MYUNG Kyungjae, made the announcement in a manuscript published in the American Association for Cancer Research on June 6th. This is a significant breakthrough for the future treatment of digestive tract cancer patients; specifically for those with DNA mismatch repair (MMR) deficient tumors.
Related Posts:Immune cell’s role in intestinal movement may lead to…Combining epigenetic therapies with immu...
Source: My Irritable Bowel Syndrome Story - June 15, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer
The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 – 7 cm.
Related Posts:EORTC-ETOP study opens on pembrolizumab designed for…Immunotherapy with live bacterium improves response rate in…Chemoradiotherapy after surgery for gastric malignancy showsNew nanopharmaceutical may help overcome resistance to…Drug shows surprising efficacy as therapy for chronic…The post Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer a...
Source: My Irritable Bowel Syndrome Story - June 13, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Receptor in nasal cavity may be linked to choice for high-fat food
The paper by Brazilian researchers released in the journal Scientific Reports identifies a study showing that a subgroup of olfactory neurons in the nasal tooth cavity express a cellular receptor specializing in the transport of lipid substances.
Related Posts:Focus on for new Rx class for inflamed disorders discoveredOne in five men reports violence toward intimate partnersAssociated with sepsis negated by Tie2 activation-induced…Drug shows surprising efficacy as therapy for chronic…Protein from bacteria alleviates food allergic reactionsThe post Receptor in nasal cavity may be linked to choice for high-fat ...
Source: My Irritable Bowel Syndrome Story - June 13, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Individuals with IBS often have negative medical care encounters
(HealthDay)—Patients suffering from serious irritable bowel syndrome (IBS) often have negative experiences of health care runs into, and actively negotiate such professional discourse by presenting a counternarrative describing their own suffering and strengths, according to a study published online Might 24 in the Journal of Clinical Nursing.
Related Posts:ASCO develops recommendations for invasive cervical…New IBS treatment shows possible in Phase 2 researchCleveland Clinic’s preventive breast cancer vaccine…Positive diagnostic strategy non-inferior to exclusion in…Non-celiac wheat sensitivit...
Source: My Irritable Bowel Syndrome Story - June 1, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
ASCO develops recommendations for invasive cervical malignancy care
(HealthDay)—The American Community for Clinical Oncology (ASCO) is rolling out guidelines for the management and palliative care of women with invasive cervical cancer. The clinical practice guide was published online May twenty five in the Journal of Global Oncology.
Related Posts:Individuals with IBS often have negative medical care…ACG: New guidelines issued for irritable bowel syndromePinaverium shows promising results for treatment of…Cleveland Clinic’s preventive breast cancer vaccine…Combining epigenetic therapies with immunotherapies likely…The post ASCO develops recommendations ...
Source: My Irritable Bowel Syndrome Story - June 1, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Clinical trial demonstrates success of reduced FODMAP diet
A change in diet can improve the lives of those diagnosed with a common, but hard-to-treat belly disorder.
Related Posts:Low FODMAP diet cuts irritable bowel syndrome symptomsWhat is Irritable Bowel SyndromeThe Perfect IBS Diet?Treatment for IBS With Severe ConstipationVery little evidence for cutting out certain carbohydrates…The post Clinical trial demonstrates success of reduced FODMAP diet appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritable Bowel Syndrome Story)
Source: My Irritable Bowel Syndrome Story - May 24, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
